Possible Association of Pulmonary Atresia with In-Utero Coxsackievirus B Exposure.
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
19
10
2021
accepted:
09
12
2021
pubmed:
14
1
2022
medline:
18
5
2022
entrez:
13
1
2022
Statut:
ppublish
Résumé
Gestational viral infection has been associated with congenital heart disease (CHD). Few studies, however, have studied the potential role of gestational Coxsackievirus B (CVB) exposure in the pathogenesis of CHD. We prospectively enrolled women with pregnancies affected by CHD to explore possible associations with in utero CVB exposure. Serum samples were obtained from 122 women referred for fetal echocardiography between 2006 and 2018. We quantified CVB IgG and IgM levels, with titers ≥ 15.0 U/mL considered positive and measured neutralizing antibodies for three CVB serotypes: CVB1, CVB3, and CVB4. Using data from the national enterovirus surveillance system, we compared the annual exposure rates for each serotype in our cohort to infections reported across the United States. 98 pregnancies with no genetic defects were included. Overall, 29.6% (29/98) had positive IgG and 4.1% (4/98) of women had positive CVB IgM titers. To explore first-trimester CVB exposure, we focused exclusively on the 26 women with positive IgG and negative IgM titers. 61.5% (16/26) had neutralizing antibodies against a single serotype and 38.5% (10/26) against multiple CVB serotypes. CVB4 neutralizing antibodies were the most common (65.4%, 17/26), followed by CVB3 (53.9%, 14/26) and CVB1 (30.8%, 8/26). Among these, 30.8% of babies presented pulmonary valve anomalies: 19.2% (5/26) pulmonary atresia, and 11.5% (3/26) pulmonary stenosis. 23.1% (6/26) of babies had coronary sinusoids. CVB exposure in our cohort mirrored that of reported infections in the United States. Our results suggest a possible association between gestational CVB exposure and specific CHD, particularly pulmonary valve anomalies and coronary sinusoids.
Identifiants
pubmed: 35022808
doi: 10.1007/s00246-021-02805-9
pii: 10.1007/s00246-021-02805-9
pmc: PMC8754073
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
960-968Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL098634
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL098634
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
J Cell Sci. 2005 Aug 1;118(Pt 15):3509-21
pubmed: 16079292
BMC Cardiovasc Disord. 2019 Dec 2;19(1):277
pubmed: 31791237
Am J Obstet Gynecol. 2014 Apr;210(4):359.e1-359.e11
pubmed: 24184180
Epidemiol Infect. 1991 Aug;107(1):iii-xiv; discussion xiii-xiv
pubmed: 1879476
Sci Rep. 2018 Aug 8;8(1):11889
pubmed: 30089864
JACC Case Rep. 2019 Oct 30;1(4):545-548
pubmed: 34316875
N Engl J Med. 1968 Jul 11;279(2):80-9 concl
pubmed: 4872379
FEBS Lett. 2020 Jun;594(12):1828-1837
pubmed: 32298477
N Engl J Med. 1964 May 14;270:1039-41
pubmed: 14122801
MMWR Morb Mortal Wkly Rep. 2015 Sep 04;64(34):940-3
pubmed: 26334674
JAMA. 1965 Dec 20;194(12):1277-83
pubmed: 5898080
Fetal Diagn Ther. 1994 Mar-Apr;9(2):77-8
pubmed: 8185842
Science. 2018 Aug 24;361(6404):800-803
pubmed: 30139872
Birth Defects Res. 2021 Apr 15;113(7):535-545
pubmed: 33369284
Clin Exp Immunol. 1968 Mar;3(3):269-76
pubmed: 5658457
J Clin Microbiol. 2006 Nov;44(11):4095-100
pubmed: 16943351
Obstet Gynecol. 2001 Dec;98(6):1019-26
pubmed: 11755547
Echocardiography. 2017 Dec;34(12):1760-1767
pubmed: 29287130
N Engl J Med. 1967 Aug 31;277(9):437-49
pubmed: 4166354
J Pathol. 2015 Jan;235(2):217-28
pubmed: 25211036
MMWR Morb Mortal Wkly Rep. 2018 May 11;67(18):515-518
pubmed: 29746455
Am J Epidemiol. 1972 Mar;95(3):207-17
pubmed: 5010819
Epidemiol Infect. 2005 Dec;133(6):1131-42
pubmed: 16274512
J Am Coll Cardiol. 2009 Apr 7;53(14):1219-26
pubmed: 19341864
JAMA. 1967 Jan 16;199(3):183-7
pubmed: 5333944
Circulation. 2007 Jun 12;115(23):2995-3014
pubmed: 17519397
MMWR Morb Mortal Wkly Rep. 2010 Dec 10;59(48):1577-80
pubmed: 21150865
Sci Rep. 2018 Mar 26;8(1):5154
pubmed: 29581446
Pediatrics. 1985 Jul;76(1):64-8
pubmed: 2989763
JAMA Pediatr. 2014 Feb;168(2):148-55
pubmed: 24311021
Gynecol Obstet Fertil Senol. 2017 Apr;45(4):231-237
pubmed: 28373042
Birth Defects Res. 2018 Oct 2;110(16):1233-1240
pubmed: 30230273
J Thorac Cardiovasc Surg. 2008 Sep;136(3):749-56
pubmed: 18805281
Clin Exp Immunol. 2012 Apr;168(1):12-23
pubmed: 22385232
J Clin Virol. 2018 Apr;101:11-17
pubmed: 29414181
EBioMedicine. 2015 Nov 27;3:86-92
pubmed: 26870820
J Am Heart Assoc. 2021 Jan 19;10(2):e017995
pubmed: 33440998
MMWR Morb Mortal Wkly Rep. 2008 May 23;57(20):553-6
pubmed: 18496504
Clin Infect Dis. 2009 Sep 1;49(5):e44-51
pubmed: 19622041
Epidemiology. 2002 Jul;13(4):485-8
pubmed: 12094106
J Am Coll Cardiol. 2001 Nov 1;38(5):1533-8
pubmed: 11691536
Congenit Heart Dis. 2015 May-Jun;10(3):209-18
pubmed: 25156087
Lancet Infect Dis. 2020 Jul;20(7):809-815
pubmed: 32330439
Brain Res Dev Brain Res. 2003 Jun 12;143(1):1-13
pubmed: 12763576
Birth Defects Res A Clin Mol Teratol. 2010 Jan;88(1):1-8
pubmed: 19697432
Radiology. 1972 Jan;102(1):153-7
pubmed: 4550314
J Am Heart Assoc. 2019 May 7;8(9):e011264
pubmed: 30995883
Science. 1969 Jul 4;165(3888):48
pubmed: 17840681